Investor Presentation • Nov 14, 2024
Investor Presentation
Open in ViewerOpens in native device viewer

De conformidad con lo establecido en el artículo 227 del texto refundido de la Ley del Mercado de Valores aprobado por el Real Decreto Legislativo 4/2015, de 23 de octubre, Inmobiliaria Colonial, SOCIMI, S.A. ("Colonial" o la "Sociedad") comunica la siguiente
Como continuación a la comunicación de otra información relevante publicada con fecha 11 de noviembre de 2024 con número de registro 31306, Colonial remite documentación de soporte para la presentación a analistas e inversores relativa a los resultados correspondientes al tercer trimestre de 2024, que se celebrará hoy jueves día 14 de noviembre de 2024 a las 18:30 horas (CET) a través de un webcast.
España: +34 917 91 85 80
R. Unido: +44 020 3428 1388
Francia: +33 172 00 1700
Alemania: +49 891 436 7081
Países Bajos: +31 20 795 2680
USA: + 1 917 444 9040
Conference ID: 345632
La presentación podrá seguirse en tiempo real, vía webcast con audioconferencia a través del siguiente enlace:
Inmobiliaria Colonial - 3rd Quarter 2024 Results
Adicionalmente, la presentación de resultados estará disponible en la página web de la Sociedad.
En Madrid, a 14 de noviembre de 2024.
Colonial
November 14th, 2024
#1
Top 1.5% Global
3Q 2024 RESULTS | 1
By attending this presentation and receiving this document, you are agreeing to be bound by the following limitations. Any failure to comply with these restrictions may constitute a violation of applicable securities laws and/or may result in civil, administrative or criminal liabilities.
This document is strictly confidential and is being furnished to you solely for your information. It may not be reproduced, or redistributed to any other person, and it may not be published, in whole or in part, for any purpose.
The information contained in this presentation ("Presentation") has been prepared by Inmobiliaria Colonial, SOCIMI S.A. (the "Company") and has not been independently verified and will not be updated. No representation, warranty or undertaking, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein and nothing in this Presentation is, or shall be relied upon as, a promise or representation. None of the Company nor any of its employees, officers, directors, advisers, representatives, agents or affiliates shall have any liability whatsoever (in negligence or otherwise, whether direct or indirect, in contract, tort or otherwise) for any loss howsoever arising from any use of this Presentation or its contents or otherwise arising in connection with this Presentation.
This Presentation is for information purposes only and is incomplete without reference to, and should be viewed solely in conjunction with, the oral briefing provided by the Company and the Company's publicly available information. The information and opinions in this presentation are provided as at the date hereof and subject to change without notice. It is not the intention to provide, and you may not rely on these materials as providing, a complete or comprehensive analysis of the Company's financial or trading position or prospects.
This Presentation does not constitute investment, legal, accounting, regulatory, taxation or other advice and does not take into account your investment objectives or legal, accounting, regulatory, taxation or financial situation or particular needs. You are solely responsible for forming your own opinions and conclusions on such matters and for making your own independent assessment of the Company. You are solely responsible for seeking independent professional advice in relation to the Company. No responsibility or liability is accepted by any person for any of the information or for any action taken by you or any of your officers, employees, agents or associates on the basis of such information.
This Presentation contains financial information regarding the businesses and assets of the Company. Such financial information may not have been audited, reviewed or verified by any independent accounting firm. The inclusion of such financial information in this Presentation or any related presentation should not be regarded as a representation or warranty by the Company, its affiliates, advisors or representatives or any other person as to the accuracy or completeness of such information's portrayal of the financial condition or results of operations by the Company and should not be relied upon when making an investment decision. Certain financial and statistical information in this document has been subject to rounding off adjustments. Accordingly, the sum of certain data may not conform to the expressed total.
Certain statements in this Presentation are forward-looking. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions which could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These include, among other factors, changing economic, business or other market conditions, changing political conditions and the prospects for growth anticipated by the Company's management. These and other factors could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this Presentation and based upon past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
The market and industry data and forecasts included in this Presentation were obtained from internal surveys, estimates, experts and studies, where appropriate as well as external market research, publicly available information and industry publications. The Company, it affiliates, directors, officers, advisors and employees have not independently verified the accuracy of any such market and industry data and forecasts and make no representations or warranties in relation thereto. Such data and forecasts are included herein for information purposes only. Accordingly, undue reliance should not be placed on any of the industry or market data contained in this Presentation.
NEITHER THIS DOCUMENT NOR ANY OF THE INFORMATION CONTAINED HEREIN CONSTITUTES AN OFFER OF PURCHASE, SALE OR EXCHANGE, NOR A REQUEST FOR AN OFFER OF PURCHASE, SALE OR EXCHANGE OF SECURITIES, OR ANY ADVICE OR RECOMMENDATION WITH RESPECT TO SUCH SECURITIES.

Agenda
01 3Q 2024 Highlights
Financial 02 Performance
03 Portfolio
Management
Future 04 Growth

01 Highlights

1) Signed rents vs. previous contracts & re-let spaces
2) ERV Growth for Colonial commercial effort .Signed rents vs 12/23 ERV (new lettings & renewals).

01 Highlights



Financial 02 Performance
Gross Rental Income growth on the back of core portfolio & project deliveries

1) Like-for-like calculated following EPRA BPR recommendations
2) Includes mainly the refurbishment of Santa Hortensia as well as other projects in Paris, Barcelona & Divestments
+12%
Solid Gross Rental Income like-for-like growth through superior pricing power

1) Like-for-like calculated following EPRA BPR recommendations


TOP RATING AGENCIES ENDORSE COLONIAL'S PRIME ASSET LEADERSHIP
"The upgrade reflects expected improvements to credit metrics with a sustainably lower leverage driven by a conservative financial policy with the benefits of recent capital increase".
Baa1 Stable Long term credit rating
Credit Rating Confirmation
"The stable outlook reflects our view that Colonial will continue to generate stable and predictable income despite economic uncertainty, on the back of the high quality of its portfolio, and its robust tenant base".

Long term credit rating
BBB+ Stable


03 Portfolio
Management




2) Signed rents vs 12/23 ERV (new lettings & renewals)

• 6,500 sqm signed with leading companies within the telecom and railway operator, among others




Future 04 Growth
04 Future Growth
We deliver strong earnings growth on the back of a multi-layer growth platform


Source of market information: CBRE

1) Based on company data: Office exposure: GAV as of 1H24
Future Growth 04


1) Total Cost = Asset Value pre project + future Capex 2) Levered IRR at EPRA LTV post capital increase

Life Science/ Healthcare
Business Campus

Occupancy 72%
€ .4 / sqm Capital Value

90%
Occupancy €2.992/ sqm Capital Value

Significant Rental Growth & Value creation Potential

Significant Rental Growth & Value creation Potential
04 Future Growth

1ToppedUp Gross rental income as of 31/12/23
2Adjusted by Sta Hortensia, Condorcet (rents in place until 01/25) & Haussmann (rents in place until 6/24)
3Includes contributed Criteria assets, Diagonal 197 & Haussmann








04 Future Growth


subsidiary, SFL (98.4%) into Inmobiliaria Colonial


https://www.inmocolonial.com/en/shareholders-and-investors

3Q 2024 RESULTS | 28

| Asset | Area | Price | GLA | Cap. Value | |
|---|---|---|---|---|---|
| EuroAthènes (Jul 2024) |
CBD | €110m | 5,123 sqm | €21,472/sqm | |
| 14 Halévy (Sep 2024) |
CBD | €230m | 10,000 sqm | €23,000/sqm | |
| 42 Montaigne (Sep 2024) |
CBD | €250m | 4,000 sqm | €62,500/sqm | |
| S RI A P |
10 Bassano (Sep 2024) |
CBD | €44m | 1,750 sqm | €25,143sqm |
| 77 Rue la Boétie (Sep 2024) |
CBD | €22m | 2,400 sqm | €9,167/sqm | |
| 11 Rue Berenguer (Oct 2024) |
CBD | €120m | 5,650 sqm | €21,239/sqm | |
| Office Gaîté Montparnasse (Oct 2024) Transaction not completed |
BD | €173m | 12,500 sqm | €13,800/sqm | |
| 48 Notre Dame des Victoires (Nov 2024) Transaction not completed |
CBD | €80m | 6,724 sqm | €11,898/sqm |
| Asset | Area | Price | GLA | Cap. Value | |
|---|---|---|---|---|---|
| Alcalá 44 (Jul 2024) |
City centre | c.€100m | 12,000 sqm | €8,333/sqm | |
| D RI D |
Zurbarán 28 (Aug 2024) |
CBD | €25m | 3,000 sqm | €33,333/sqm |
| A M |
Ramírez de Prado 5 (Oct 2024) |
City centre | €340m1 | 12,000 sqm | n.a. |
| Avda. Tenerife 4 (Oct 2024) |
Secondary | c.€47m | n.a. | n.a. | |
| Berlin 38 (Jul 2024) |
City centre | €50m | 13,280 sqm | €3,765/sqm | |
| A N O L E C R A B |
Tarraco Tower (Aug 2024) |
City centre | €90m | 20,000 sqm | €4,500/sqm |
| Passeig de Gracia 110 & Diagonal 431 (Oct 2024) Mixed use asset |
CBD | n.a. | 11,500 sqm | n.a. |
1) The transaction price includes four additional assets, with the Amazon headquarters recorded in balance sheet at approximately €274 million
Source: public information, press and consultants
| Results analysis - €m |
3Q 2024 |
3Q 2023 |
|
|---|---|---|---|
| Gross Rents |
293 | 279 | |
| Net operting expenses & Overheads |
(51) | (46) | |
| Recurring EBITDA |
242 | 233 | |
| Recurring financial result |
(58) | (71) | |
| Income tax expense & others - recurring |
(7) | (8) | |
| Minority interests - recurring |
(29) | (26) | |
| Recurring Earnings |
147 | 129 | |
| Change in fair value of assets & provision |
(13) | (525) | |
| Non-recurring financial result & MTM |
(2) | (1) | |
| Income tax & others - non-recurring |
63 | 10 | |
| Minority interests - non-recurring |
(39) | 89 | |
| Profit attributable to the Group |
156 | (299) | |
| - €m | 147 | 129 | |
| ecurring earnings Nosh (mm) |
568 | 540 | |
| EPS recurring - Cts€/share |
25.9 | 23.8 |

+5% YoY
+6% Like-



Maturity profile of debt facilities - €m

| 31/12/2023 | 30/09/2024 | ||
|---|---|---|---|
| Net Debt |
€ 86 m | € 1 m |
|
| LTV | 39.5%2 | 36.5%2 | |
| Total Facilities |
€ 65m |
||
| Cash | € 8m | €87 m | |
| Liquidity | € m |
€ m |
|
| Debt Maturity Group |
4.2 years | 4.2 years | |
| Non-Mortgage debt |
100% | 100% | |
| Cost of Debt Group |
1.75%3 | 1.72%3 | |
1) Excluding ECPs
2) Including sales commitments already formalized and sale commitment of Méndez Álvaro Residential + Criteria Caixa Capital increase in July 2024
3) Excluding formalization costs accrued over the life of debt.


| Project | Use | Delivery | GLA (sqm) |
Total €m1 Cost |
Ungeared IRR |
|---|---|---|---|---|---|
| Scope Paris City Center |
Business Campus |
2026 | 22.000 | 309 | > 9% |
| Sancho de Ávila Barcelona 22@ |
Life Science/ Healthcare |
2027 | 17.860 | 114 | > 7% |
| Condorcet Paris City Center |
Urban Mixed-Use |
2027 | 24.000 | 366 | >9% |
| Santa Hortensia Madrid City Center |
Urban Mixed-Use |
2028 | 46.928 | 237 | >9% |
| 110.788 | 1.026 | >9% |


Sancho de Ávila Life Science/ Healthcare




1) Condorcet tenant leaves at 31/01/25 & Haussmann at 01/07/2024
2) Adjusted by Sta Hortensia, Condorcet & Haussmann
3) Includes contributed assets & Renovation Programs on Diagonal 197 & Haussmann


© 2024 Colonial www.inmocolonial.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.